TELA vs. APYX, ICAD, TTOO, CODX, UTMD, IRMD, BVS, OFIX, ANIK, and TMCI
Should you be buying TELA Bio stock or one of its competitors? The main competitors of TELA Bio include Apyx Medical (APYX), iCAD (ICAD), T2 Biosystems (TTOO), Co-Diagnostics (CODX), Utah Medical Products (UTMD), Iradimed (IRMD), Bioventus (BVS), Orthofix Medical (OFIX), Anika Therapeutics (ANIK), and Treace Medical Concepts (TMCI). These companies are all part of the "surgical & medical instruments" industry.
TELA Bio (NASDAQ:TELA) and Apyx Medical (NASDAQ:APYX) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, valuation, institutional ownership, earnings, analyst recommendations, community ranking, risk, media sentiment and profitability.
Apyx Medical has lower revenue, but higher earnings than TELA Bio. TELA Bio is trading at a lower price-to-earnings ratio than Apyx Medical, indicating that it is currently the more affordable of the two stocks.
TELA Bio presently has a consensus target price of $13.00, suggesting a potential upside of 132.14%. Apyx Medical has a consensus target price of $6.17, suggesting a potential upside of 285.42%. Given Apyx Medical's higher possible upside, analysts plainly believe Apyx Medical is more favorable than TELA Bio.
94.4% of TELA Bio shares are held by institutional investors. Comparatively, 55.3% of Apyx Medical shares are held by institutional investors. 6.0% of TELA Bio shares are held by company insiders. Comparatively, 13.1% of Apyx Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
TELA Bio has a beta of 1.04, meaning that its stock price is 4% more volatile than the S&P 500. Comparatively, Apyx Medical has a beta of 1.25, meaning that its stock price is 25% more volatile than the S&P 500.
In the previous week, Apyx Medical had 1 more articles in the media than TELA Bio. MarketBeat recorded 2 mentions for Apyx Medical and 1 mentions for TELA Bio. Apyx Medical's average media sentiment score of 1.61 beat TELA Bio's score of 0.00 indicating that Apyx Medical is being referred to more favorably in the news media.
Apyx Medical received 25 more outperform votes than TELA Bio when rated by MarketBeat users. However, 72.22% of users gave TELA Bio an outperform vote while only 61.60% of users gave Apyx Medical an outperform vote.
Apyx Medical has a net margin of -45.20% compared to TELA Bio's net margin of -63.82%. Apyx Medical's return on equity of -76.16% beat TELA Bio's return on equity.
Summary
Apyx Medical beats TELA Bio on 12 of the 17 factors compared between the two stocks.
Get TELA Bio News Delivered to You Automatically
Sign up to receive the latest news and ratings for TELA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding TELA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
TELA Bio Competitors List
Related Companies and Tools
